|
|
|
 |
FDA Approval Activities for this Drug…
ACETAZOLAMIDE Capsule, Extended Release; 500MG DIAMOX DURAMED Barr 008943 ACETAZOLAMIDE Tablet; 125MG DIAMOX DURAMED Barr 008943 ACETAZOLAMIDE Tablet; 250MG DIAMOX DURAMED Barr 084840 ACETAZOLAMIDE Tablet; 250MG ACETAZOLAMIDE LANNETT 089752 ACETAZOLAMIDE Tablet; 125MG ACETAZOLAMIDE Mutual 089753 ACETAZOLAMIDE Tablet; 250MG ACETAZOLAMIDE Mutual 040195 ACETAZOLAMIDE Tablet; 125MG ACETAZOLAMIDE Taro 040195 ACETAZOLAMIDE Tablet; 250MG ACETAZOLAMIDE Taro 088882 ACETAZOLAMIDE Tablet; 250MG ACETAZOLAMIDE Watson 040108 ACETAZOLAMIDE SODIUM Injection 500MG BASE/VIAL ACETAZOLAMIDE SODIUM Abbott 040089 ACETAZOLAMIDE SODIUM Injection 500MG BASE/VIAL ACETAZOLAMIDE SODIUM Bedford 009388 ACETAZOLAMIDE SODIUM Injection 500MG BASE/VIAL DIAMOX DURAMED Barr | Diamox Sequels (acetazolamide) sustained-release capsules, Duramed Pharma, Manufacturing Change or Addition & Labeling Revision | Acetazolamide Extended-Release Capsules, Zydus Pharmaceuticals USA, Inc., Approval | Acetazolamide Sodium Injection, X-Gen Pharmaceuticals, Inc., Approval | Acetazolamide Extended-Release Capsules, Indicus Pharma, LLC., Approval
  
|